Investment Rating - The report maintains an "Outperform" rating for the public utility and environmental sectors [1][4]. Core Insights - The report emphasizes the high-quality development of the environmental equipment manufacturing industry, aiming to create a trillion-level industry with international competitiveness by 2027 [2][16]. - It highlights the synergy between computing power and electricity, particularly in the context of data centers, which require substantial and reliable electricity supply [18][20]. - The report suggests that the profitability of coal-fired power generation is expected to remain reasonable due to the simultaneous decline in coal and electricity prices [28]. Summary by Sections Market Review - The Shanghai Composite Index rose by 1.59%, while the public utility index increased by 2.19% and the environmental index by 2.53% [1][29]. - Among the sub-sectors, coal-fired power saw a 3.39% increase, while renewable energy generation rose by 1.48% [31]. Important Policies and Events - The Ministry of Industry and Information Technology, the Ministry of Ecology and Environment, and the State Administration for Market Regulation jointly issued opinions to promote the high-quality development of the environmental equipment manufacturing industry [2][16]. - By 2030, the report anticipates a complete upgrade of the environmental equipment manufacturing industry towards green, low-carbon, and circular development [2]. Investment Strategy - Recommendations include major coal-fired power companies like Huadian International and regional power companies like Shanghai Electric due to stable electricity prices [3][28]. - For renewable energy, leading companies such as Longyuan Power and Three Gorges Energy are recommended, alongside regional offshore wind power companies [3][28]. - The report also suggests focusing on water and waste incineration sectors, which are entering a mature phase with improved free cash flow [3][28]. Industry Dynamics - The report notes that the electricity and heat production and supply industry prices fell by 0.8% year-on-year in February 2025 [17]. - It highlights the increasing importance of green electricity and nuclear power in meeting the energy demands of data centers [24][21]. Company Performance - The report lists several companies with "Outperform" ratings, including Huadian International, Longyuan Power, and China Nuclear Power, among others, indicating their strong market positions and growth potential [6][28].

国产科学仪器龙头经营拐点显现，设备更新+国产替代助力发展 聚光科技：国产高端仪器装备领军企业。公司是一家以高端仪器装备产品 技术为核心的高科技平台型企业，仪器业务占主营业务收入的比重维持 在 70%左右。2009-2018，公司的营收由 5.3 亿增长至 38.2 亿元，CAGR 高达 24.5%；归母净利润由 1.32 亿增长至 6.01 亿，CAGR 高达 18.34%。 后因 PPP 项目拖累等原因发展陷入瓶颈期连年亏损。2025 年 1 月公司发 布业绩预告实现归母净利 2-2.3 亿元，这是公司自 2020 年来首次盈利。 科学仪器行业：大国崛起下的黄金赛道。科学仪器是用以检出、测量、观察、 计算各种物理量、物质成分、物性参数等的器具或设备，广泛应用于环境、 科研、生命科学、半导体、三方检测等下游。全球科学仪器市场规模由 2015 年的 514 亿美元增至 2022 年的 747 亿美元，中国市场容量排在全球第三， 市场份额超过 90 亿美元，但大部分高端仪器的国产渗透率不足 1.5%，国内 科学仪器公司在市值、收入利润和产品布局上均与海外龙头差距明显。 4+X 战略布局，覆盖下游多行业。公司在智慧 ...

证券研究报告 | 2025年03月05日 聚光科技（300203.SZ） 优于大市 国产科学仪器龙头经营拐点显现，设备更新+国产替代助力发展 聚光科技：国产高端仪器装备领军企业。公司是一家以高端仪器装备产品 技术为核心的高科技平台型企业，仪器业务占主营业务收入的比重维持 在 70%左右。2009-2018，公司的营收由 5.3 亿增长至 38.2 亿元，CAGR 高达 24.5%；归母净利润由 1.32 亿增长至 6.01 亿，CAGR 高达 18.34%。 后因 PPP 项目拖累等原因发展陷入瓶颈期连年亏损。2025 年 1 月公司发 布业绩预告实现归母净利 2-2.3 亿元，这是公司自 2020 年来首次盈利。 科学仪器行业：大国崛起下的黄金赛道。科学仪器是用以检出、测量、观察、 计算各种物理量、物质成分、物性参数等的器具或设备，广泛应用于环境、 科研、生命科学、半导体、三方检测等下游。全球科学仪器市场规模由 2015 年的 514 亿美元增至 2022 年的 747 亿美元，中国市场容量排在全球第三， 市场份额超过 90 亿美元，但大部分高端仪器的国产渗透率不足 1.5%，国内 科学仪器公司在市值、收入 ...

| 投资者关系活 | □特定对象调研 | □分析师会议 | | --- | --- | --- | | 动类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | □一对一沟通 | | | ■其他（电话会议调研） | | | 参与单位名称 | 磐耀资管、人保养老、民生加银基金、万家基金、观富资管、东 | | | 及人员姓名 | 北证券、天弘基金、西部证券、国信证券、平安资产、工银瑞信、 | | | | 星石投资、淳厚基金、银华基金、鹏华基金、鑫元基金、中金资 | | | | 管、汐泰投资、湘禾投资、长江环保、招商证券资管、泓德基金、 | | | | 华宝基金、宏利基金、汇添富基金、中银资管、兴业基金、青榕 | | | | 资产、华商基金、信诚基金、财通基金、广发证券、国金基金、 | | | | 睿远基金、诺安基金、广发基金、嘉实基金、平安养老、融通基 | | | | 金、金信基金、安信基金、人保资产、建信基金、钧泽基金、建 | | | | 信养老、合远私募基金、诺德基金、国泰基金、长信基金、浦银 | | | | 安盛基金、国联基金、太平养老、美港资本、中邮证 ...

Summary of Key Points from the Conference Call of 聚光科技 Company Overview - 聚光科技 focuses on strategic and boutique strategies, concentrating resources on technologically advanced products while implementing refined management. The goal is to double performance with minimal personnel growth while actively promoting import substitution and domestic replacement, and expanding into emerging fields such as semiconductors, new materials, and biomedicine [2][4][5]. Financial Performance - In 2024, 聚光科技 achieved a revenue growth of 15%, with improvements in gross margin and absolute gross profit. Cost control measures led to a reduction in expenses by approximately 30 to 40 million [3][4]. - The operating cash flow saw a significant increase of 700 million, marking 2024 as a year of recovery from previous lows [3][4]. Business Segment Performance - The company’s business segments showed varied performance: - Industrial process products provided stable cash flow. - The environmental segment achieved significant profitability. - The technology information segment is expected to continue growing profitably. - The medical segment is in a phase of revenue growth and nearing profitability. - The strategic market department is focused on developing emerging industries [2][6]. Strategic Initiatives - 聚光科技 has established an AI task force to deploy localized applications of large models post-Spring Festival, aiming to reduce costs and improve operational efficiency through AI technology [2][8]. - The company is actively pursuing import substitution and domestic replacement, particularly in fields like ECG analysis, cell therapy, and proteomics, while optimizing supply chain management to enhance innovation capabilities [2][7]. Market Trends and Opportunities - Demand for scientific instruments from universities and research institutions is recovering, driven by national customs investments and food safety management system construction, which is expected to increase related detection equipment demand [4][16]. - The industrial automation and environmental monitoring instrument sectors are projected to grow by up to 10 times, while the scientific instrument business is expected to grow by 30% to 50% [4][18]. Future Outlook - The company anticipates that achieving a doubling of revenue will take approximately 4 to 5 years, contingent on the acceleration of domestic substitution initiatives [26]. - The overall revenue growth for 2024 was 20%, with expectations for continued positive performance in 2025 [39]. Challenges and Responses - 聚光科技 is addressing the impacts of international policy changes, particularly regarding U.S. export controls on high-end instruments, by enhancing domestic capabilities and seeking alternative solutions [12][7]. - The company is also adapting to changes in procurement policies from institutions like the Academy of Sciences, which are increasingly favoring domestic equipment [38]. Employee and Talent Management - As of the end of 2024, 聚光科技 had approximately 5,000 employees, with plans for structural optimization and an increase in high-quality talent recruitment [41][28]. Conclusion - 聚光科技 is positioned for growth through strategic focus on high-tech products, effective cost management, and responsiveness to market demands and international challenges. The company is optimistic about its future performance and aims to leverage emerging opportunities in various sectors.

Summary of Conference Call Records Company and Industry Overview - The conference call discusses the performance and strategic direction of a company in the scientific instruments and technology sector, particularly focusing on its recovery from previous losses and growth strategies for the upcoming years [1][4][7]. Key Points and Arguments 1. **Financial Performance**: The company has successfully turned around from previous losses, achieving a revenue growth of 12.5% year-over-year, with a net profit of 150 million [1][2]. 2. **Strategic Changes**: The management has implemented significant strategic changes aimed at enhancing operational efficiency and product quality, focusing on a "boutique strategy" to ensure all products meet high standards [5][26]. 3. **Market Conditions**: The macroeconomic environment remains challenging, but there is optimism regarding future growth driven by government policies and market demand for domestic products [3][14]. 4. **Investment in AI and Technology**: The company is actively investing in AI technologies to improve operational efficiency and product offerings, with plans to integrate AI into various product lines [6][19]. 5. **Sector Focus**: The company is concentrating on specific sectors such as environmental products, medical devices, and industrial applications, which are expected to drive future growth [7][9]. 6. **Government Policies**: Recent government policies favoring domestic production and technology are seen as beneficial for the company, particularly in light of export restrictions on certain high-end instruments [14][15]. 7. **Market Share and Growth Potential**: The company aims to increase its market share in the scientific instruments sector, with expectations of continued growth in both revenue and profit margins [21][25]. 8. **Challenges and Risks**: There are concerns regarding potential declines in government spending and the impact of international relations on business operations, but the company remains committed to navigating these challenges [21][30]. Additional Important Content - **Product Development**: The company is focusing on developing high-end scientific instruments and enhancing its product portfolio to meet market demands [48][49]. - **Employee Stability**: Management reassured stakeholders about the stability of the leadership team and the commitment of employees to the company's long-term vision [44][45]. - **Future Outlook**: The company is optimistic about achieving significant growth in the coming years, with projections of doubling revenue within four to five years [37][38]. This summary encapsulates the key discussions and insights from the conference call, highlighting the company's strategic direction, financial performance, and market outlook.

Investment Rating - The report gives a "Buy" rating for the company, indicating an expected relative increase in stock price of over 20% compared to the benchmark index within six months [6][14]. Core Insights - The company is expected to achieve a net profit attributable to shareholders of 200-230 million yuan in 2024, marking a significant turnaround from previous losses. The fourth quarter alone is projected to yield a net profit of 82-112 million yuan [3][4]. - The main business revenue is anticipated to grow steadily by 10-15%, with a specific segment, Puyue Technology, achieving a revenue growth of approximately 20% [4]. - The company is focusing on high-end analytical instruments, optimizing costs and enhancing efficiency, which has led to improved gross margins and reduced expenses [4][5]. Company Overview - The latest closing price of the company's stock is 17.27 yuan, with a total market capitalization of 7.7 billion yuan. The company has a total share capital of 449 million shares, with a debt-to-asset ratio of 67.5% [2]. - The company has a significant opportunity in the high-end analytical instrument market, where domestic production is still low, and there is a pressing need for local alternatives to imported products [5]. Financial Forecast and Valuation - Revenue projections for 2024-2026 are 35.96 billion, 40.34 billion, and 44.89 billion yuan, respectively, with year-on-year growth rates of 13.02%, 12.19%, and 11.26% [6][10]. - The net profit attributable to shareholders is expected to reach 215 million, 306 million, and 386 million yuan for the same period, with growth rates of 166.77%, 42.10%, and 26.21% [6][10]. - The company's price-to-earnings (P/E) ratios for 2024-2026 are projected to be 35.97, 25.32, and 20.06, indicating a relatively low valuation compared to peers [6][10].

Financial Performance Expectations - The company expects a net profit attributable to shareholders of approximately RMB 200 million to RMB 230 million for 2024, compared to a loss of RMB 322.65 million in the same period last year[3]. - The net profit after deducting non-recurring gains and losses is projected to be between RMB 120 million and RMB 150 million, compared to a loss of RMB 388.28 million in the previous year[3]. - The company's main business revenue is expected to grow by approximately 10% to 15% in 2024, with an improvement in gross profit margin[6]. - The net cash flow from operating activities is estimated to be around RMB 700 million for the reporting period[6]. - Non-recurring gains and losses for 2024 are expected to be about RMB 80 million, primarily from government subsidies[6]. - The company anticipates a goodwill impairment of approximately RMB 30 million to RMB 40 million for the reporting period[6]. Subsidiary Performance - The subsidiary, Hangzhou Puyue Technology, achieved a revenue growth of approximately 20% compared to 2023, with a profit of about RMB 150 million[7]. Strategic Focus and Cost Management - The company plans to focus on high-end analytical instruments and related products, optimizing resources and reducing non-profitable business lines[5]. - The company has implemented cost control measures, resulting in a decrease in various expense amounts[6]. Future Reporting - The specific financial data for 2024 will be detailed in the annual report after evaluation and audit by professional institutions[8].

证券代码：300203 证券简称：聚光科技 公告编号：2024-040 聚光科技（杭州）股份有限公司 关于审计机构变更项目质量控制复核人的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 聚光科技（杭州）股份有限公司（以下简称"公司"或"聚光科技"）分别 于2024年4月21日召开第四届董事会第十三次会议及第四届监事会第十次会议、 于2024年5月15日召开2023年年度股东大会，审议通过了《关于续聘公司2024年 度审计机构的议案》，同意续聘中审众环会计师事务所（特殊普通合伙）（以下 简称"中审众环"）为公司2024年度审计机构。具体内容详见公司分别于2024年4 月23日、2024年5月15日在巨潮资讯网（http://www.cninfo.com.cn）披露的《关 于续聘会计师事务所的公告》等相关公告。 | 时间 | 上市公司名称 | 职务 | | --- | --- | --- | | 2022-2023 年 | 浙江乔治白服饰股份有限公司 | 质量控制复核人 | | 2023 年 | 宁波一彬电子科技股份有限公司 | 质量控制复核人 | | 2023 ...

证券代码：300203 证券简称：聚光科技 公告编号：2024-039 聚光科技（杭州）股份有限公司 关于公司及子公司获得政府补助的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、获得补助的基本情况 聚光科技（杭州）股份有限公司（以下简称"公司"、"聚光科技"）及子 公司自 2024 年 09 月 03 日至 2024 年 12 月 04 日累计收到各项政府补助资金共计 人民币 66,608,321.60 元，其中增值税即征即退资金为人民币 23,032,436.40 元，与公司日常经营活动密切相关，具有可持续性；其他政府补助资金为人民币 43,575,885.20 元。现将具体情况分别列示如下： | 获得补助的 | 提供补 助的主 | 项目 | 本期收到补助 | 本期收到补助的 | 补助 | 会计 | | --- | --- | --- | --- | --- | --- | --- | | 主体 | | | 时间 | 金额 | 类型 | 处理 | | | 体 | | | | | | | 杭州谱育科 | 中国 21 世纪议 | 抗振动分子 泵在便携桌 面 ...